Clinical therapeutic recommendation on duloxtine in treatment of major depressive disorder and generalized anxiety disorder
JIANG Kai-da~1;LI Ling-jiang~2;WANG Gang~3;SI Tian-mei~4;HUANG Ji-zhong~1;XU Xiu-feng~5; FANG Yi-ru~1;LI Hui-chun~6;LU Zheng~7;MEI Qi-yi~8;JIA Fu-jun~9;LI Tao~;ZHAO Jing-ping~2; WU Wen-yuan~7;ZHANG Ming-yuan~1

..............page:520-536

Focus on safety of proton pump inhibitors
LIU Fei;ZHENG Song-bai

..............page:493-498

A controlled clinical study of aripiprazole combined with SSRIs vs.chlorimi-pramine in treatment of SSRIs refractory obsessive-compulsive disorder
XIA Jing;ZHAN Yu-hua;WANG Xu-mei

..............page:553-556

Influence of CYP2D6 genetic polymorphism on pharmacokinetics of paroxetine in Chinese healthy people
WANG Meng;ZHOU Wen-jia;XIAO Li;ZHANG Quan-ying

..............page:548-552

Effects of sitagliptin combined insulin on 46 patients with type 2 diabetes mellitus
FANG Wen-jun;JIAN Wei-xia;HU Jing-fang;QIN Li;SU Qing

..............page:557-560

Pharmacology and clinical evaluation of vilazodone
ZHU Yi;FENG Yu-fei

..............page:516-519

guang zhou yi xue yuan di er fu shu yi yuan xin nei ke

..............page:569

A study:adverse drug reactions to infliximab treatment in patients with inflammatory arthritis
XIA Xiao-ru;WANG Jian;WANG Bo;CHEN Pei-rong;QIN Wei;ZHU Xiao-chun

..............page:565-568

An overview of marketed combined oral contraceptives approved by FDA from 2007 to 2011
HUANG Ting~1;ZENG Jia~1;CAO Yun-feng~1;XIE Xiao-yu~2;ZHENG Wei~1;CHEN Liang-kang~1; CHEN Jian-xing~1

..............page:498-504

Study on pharmacokinetics of rupatadine tablet in Chinese healthy volunteers
ZHOU Lun;YANG Lin;JIA Yan-yan;YANG Jing;SONG Wei;LI Xue-qing;SONG Ying; LU Cheng-tao;WEN Ai-dong

..............page:561-565

Pharmacokinetics of YL-0919 in mice by liquid chromatography-tandem mass spectrometry
DENG Ming~;LI Jing-lai~1;QIAO Jian-zhong~1;LI Chang-kun~1;LI Yun-feng~1;ZHANG Zhen-qing~1

..............page:537-542

Clinical value of rapid-acting intramuscular second generation antipsychotics in management of acute agitation of schizophrenia
LI Hui-pu~1;HUANG Ji-zhong~2

..............page:511-515

Experimental research on application of bacteriophage AB3 and its liposome coating solution in carbapenem-resistant Acinetobacter baumannii infection
ZHANG Jie;LUO Yong-ai;ZHOU Li-rong

..............page:543-548

Advances in coagulation factor Xa inhibitor
HUANG Zhen-hua

..............page:505-510